Polypeptides for inducing a protective immune response against Staphylococcus aureus

Details for Australian Patent Application No. 2009319947 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McNeely, Tessie B.; Cope, Leslie D.; Miller, Mark A.; Schultz, Loren D.; Wang, Xinmin

Agent Spruson & Ferguson

Pub. Number AU-A-2009319947

PCT Pub. Number WO2010/062815

Priority 61/200,309 26.11.08 US

Filing date 18 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/062815 Priority application(s): WO2010/062815

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319949-RNA interference mediated inhibition of epithelial sodium channel (ENaC) gene expression using short interfering nucleic acid (siNA)

2009319946-Polypeptides for inducing a protective immune response against Staphylococcus aureus